OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

1 min readOriginal

OpenAI is acquiring Orchestra Bio to bring AI powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Read the full post on OpenAI News →

Originally published on

OpenAI News

Read original

Keep reading